Oncology
Clayton D. Watkins, DVM (he/him/his)
Veterinarian, owner
VetMed Consultants
Holladay, Utah, United States
Radiation therapy remains the standard of care for canine sinonasal tumors; however, accessibility, cost, and comorbidities frequently limit its use. Historically, surgical management via open rhinotomy has been associated with significant morbidity, restricting its role in treatment options. Advancements in endoscopic visualization and surgical instrumentation have expanded minimally invasive options in veterinary oncology.
This session will review outcomes from 76 dogs with intranasal neoplasia treated using a novel ENTR technique between 2014 and 2025. Tumor distribution, Modified Adam’s staging, and survival data will be presented with emphasis on clinical interpretation rather than statistical methodology. Median survival time, staging impact, and correlations between resection approach and outcome will be discussed in the context of practical case selection.
Attendees will learn how to determine when ENTR may be appropriate as:
A palliative option when radiation therapy is unavailable
A debulking strategy prior to radiation therapy
A component of multimodal management
This session will provide clinicians with practical guidance for integrating endoscopic tumor resection into treatment algorithms for canine sinonasal neoplasia.